On being asked about inoculation of people above 18 years of age from May 01, Delhi Health Minister Satyendar Jain on April 29 informed that as of now, the Delhi government don't have vaccines and have made requests to the company regarding vaccines.
"We don't have vaccines as of now.
We have made requests to the company regarding vaccines, we will tell you when it comes," Delhi Health Minister informed mediapersons.
From May 01, the third phase of India's COVID vaccination drive will begin for all citizens of 18 years of age and above to get vaccines.
A Delhi court extended AAP MLA Amanatullah Khan's judicial custody till November 16 in the Delhi Waqf Board money laundering case. The Enforcement Directorate.. IndiaTimes
The Supreme Court emphasized the need to manage pollution caused by firecrackers, cautioning that unchecked pollution contributes to disorder and health risks. DNA
In areas like Punjabi Bagh, Wazirpur, Ashok Vihar, Bawana, Jahangirpuri, Mundka, Rohini, Moti Bagh, and Patparganj, the air quality worsened with AQI hit the.. DNA
A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccine’s potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research.
#IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity
~HT.97~PR.152~
Passengers filled Delhi's Indira Gandhi International Airport late Friday night (April 30) as the "double mutant" strain of Covid-19 rages in India and residents fear increasing travel bans for interna
World Projected to Spend $157 Billion
on COVID-19 Vaccines by 2025.
On Thursday, IQVIA Holdings Inc released a report
detailing global spending on COVID-19 vaccines. .
According to the U.S. health..
Credit: Wibbitz Top Stories Duration: 01:04Published
Even as the phase-3 vaccination against COVID-19, covering people between 18-45 years, is scheduled to start from May 01 across the country, several states have said they don't have the vaccines..